Weight-loss Medication Support

Medical follow-up for GLP-1/GIP medicines used in obesity care, such as Mounjaro (tirzepatide), after suitability assessment and under qualified medical supervision.

PART OF ONE TEAM

This expertise supports your journey — it is not a separate appointment.

When relevant, this expertise informs your assessment, plan, and follow-up inside INSTACARE 360.

How it supports care

Suitability review, physician follow-up, nutrition follow-up

Clinical and medication decisions — including medicines such as Mounjaro — remain under qualified medical supervision following appropriate assessment.

Start INSTACARE 360